ASML warns it may not achieve growth in 2026
Analysts had hoped that the quarter would provide some reassurance over its outlook for 2026. However, the company warned that geopolitical uncertainty continued to cloud its prospects.
"We continue to see increasing uncertainty driven by macro-economic and geopolitical developments", ASML's chief executive Christophe Fouquet said in a statement.
The Dutch group's net bookings, the most closely watched figure in the industry, were 5.54 billion euros ($6.4 billion). That was ahead of analysts' consensus estimate of 4.44 billion euros according to researcher Visible Alpha.
($1 = 0.8608 euros)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Why Google should 'walk away' from Waymo
Needham & Company senior media and internet analyst Laura Martin joins Market Domination with Josh Lipton to explain why Alphabet (GOOG, GOOGL) should ditch Waymo and focus on generative artificial intelligence (AI) instead. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. Related videos The £70bn pension tax raid Reeves may not be able to resist 10 shares I wouldn't want to hold in a stock market crash After falling 16% in a day, this stock's on my list of shares to buy in August This FTSE 250 trust is easily beating the global index in 2025. Time to buy? Sign in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
Pfizer (PFE) Receives CHMP Recommendation For Adapted COVID-19 Vaccine COMIRNATY
BioNTech SE and Pfizer recently received a positive recommendation from the European Medicines Agency for marketing authorization of their COVID-19 vaccine, which likely contributed to Pfizer's share price increase of 8% in the last quarter. The company's advancements in COVID-19 vaccine development, alongside other product-related announcements like the XTANDI and BRAFTOVI trial results, added weight to this upward movement. Despite legal challenges and declining earnings, Pfizer's focus on innovation and strategic partnerships like the one with XtalPi possibly countered broader market moves, which saw a smaller 1% increase in the same period. We've identified 3 warning signs for Pfizer that you should be aware of. Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave. The recent positive recommendation from the European Medicines Agency for the COVID-19 vaccine developed by BioNTech SE and Pfizer has contributed to an 8% increase in Pfizer's share price over the last quarter. This news may provide a temporary boost to Pfizer's revenue and earnings forecasts, especially as the company continues to innovate amidst legal challenges and declining earnings. The authorization could enhance immediate market confidence in Pfizer's product pipeline, impacting future revenue projections positively. Over the past year, Pfizer experienced a total return of 13.78% including dividends, reflecting a challenging period for shareholders. When compared to the broader US market's return of 17.2% over the same period, Pfizer has underperformed, highlighting investor concerns over competitive pressures and revenue growth prospects. The current share price movement toward the analyst consensus price target of $29.23 suggests a cautiously optimistic outlook among some market participants. Analysts' revenue forecasts reflect potential declines due to increased competition for existing products, yet others anticipate that strategic shifts in research focus, especially in oncology, might mitigate future earnings risks. With a modest increase of 8% in shares largely tied to vaccine authorization, it underscores the uncertainty surrounding longer-term performance relative to bearish analyst expectations. Understand Pfizer's track record by examining our performance history report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include PFE. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Forbes
23 minutes ago
- Forbes
Pixel 10 Pro Price Leak Confirms Google's Bold Decisions
Pixel 9 Pro XL As Google prepares to announce the Pixel 10 and Pixel 10 Pro in late August, some of the biggest questions have been about the price of the new handsets. With flagship phones from the likes of Apple and Samsung regularly pushing base models into four-figure prices, how competitive will Google's pricing decisions be and what do they say about its strategy? Pixel 10 And Pixel 10 Pro Pricing We have European pricing across the four main models, which are broadly similar to the pricing of the Pixel 9 family. The Pixel 10 starts at €899 for 128 GB, the Pixel 10 Pro at €1,099 also for 128 GB, and the Pixel 10 Pro XL listings drop the 128 GB option to start at €1,299 for 256 GB. Finally, the Pixel 10 Pro Fold starts at € 1,899 for 256 GB. Both the Pro XL and the Pro Fold, sitting at the top of the portfolio, do not have 128 GB versions listed. That's not to say the 128 GB option is definitely gone—perhaps these will be available only through the Google Store, region-locked, or as network exclusives. We shall see during the Made By Google launch event scheduled for Aug. 20. By echoing 2024's pricing across the range, Google offers us a glimpse into the wider strategy it is using to address both the consumer market and its Android Partners. Pixel 10 And Pixel 10 Pro Strategy The steady approach to pricing—which is arguably mirrored by the incremental updates to the physical design of the Pixel 10 family over the Pixel 9—shows Google's confidence in the market. There may be new features added to the hardware and software of the Pixel package, but the value proposition has not changed; so neither has the price. That could be a quiet victory on retail shelves. There's an expectation that the price of the new model will rise compared to the existing model. Because the counterpoint to this is that if Google did lift the prices on the Pixel models, then the difference between its smartphones and the likes of the iPhone Pro or Galaxy S Ultra models would be more apparent; the increased performance of the latter would be noticeable, and the value conscious consumer would look at the closer pricing and decide that the jump to a more recognisable phone brand would be easier to make. Yet there is something more for the price-conscious buyer. Because of the lower starting price for each model, moving up to a model with increased storage feels like good value, in part due to keeping the Pixels lower than the entry-level pricing of the aforementioned Apple and Samsung devices. Finding Value In The Pixel 10 And Pixel 10 Pro Pricing for the Pixel 10 Pro and the rest of the Pixel 10 lineup is familiar. Google continues to offer a flagship experience at a price that will be perceived as lower than that of its competitors' flagships. Part of me wonders if this is because the real value in the Pixel family for Google is in the software and subscription services such as Google One and Google Gemini. Now read the latest Pixel 10 Pro, Samsung Galaxy, and smartphone news in Forbes' weekly Android news digest...
